Compugen (TA:CGEN) — Stock Price
Compugen (TA:CGEN) is currently trading at ILA720.00 ILA, down 2.98% today. Over the past 52 weeks, shares have ranged between ILA462.80 and ILA924.00. This page tracks Compugen's live share price on the TA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CGEN market cap overview.
Compugen (CGEN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Compugen's daily closing share price and trading volume on the TA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Compugen Income Statement — Revenue, Profit & Earnings by Year
Compugen's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | ILA72.76 Million | ILA27.86 Million | ILA33.46 Million | ILA7.50 Million | ILA6.00 Million |
| Cost of Revenue | ILA9.25 Million | ILA7.93 Million | ILA2.00 Million | ILA975.00K | ILA680.00K |
| Gross Profit | ILA63.51 Million | ILA19.93 Million | ILA31.45 Million | ILA6.53 Million | ILA5.32 Million |
| Research & Development | ILA22.76 Million | ILA24.81 Million | ILA34.47 Million | ILA30.65 Million | ILA28.69 Million |
| SG&A | ILA8.89 Million | ILA9.44 Million | ILA9.73 Million | ILA11.25 Million | ILA11.70 Million |
| Total Operating Expenses | ILA32.19 Million | ILA34.83 Million | ILA44.45 Million | ILA42.87 Million | ILA41.07 Million |
| Operating Income | ILA31.33 Million | ILA-14.89 Million | ILA-12.99 Million | ILA-35.37 Million | ILA-35.07 Million |
| EBITDA | ILA31.80 Million | ILA-14.40 Million | ILA-12.52 Million | ILA-34.89 Million | ILA-34.61 Million |
| EBIT | ILA31.33 Million | ILA-14.89 Million | ILA-12.99 Million | ILA-35.37 Million | ILA-35.07 Million |
| Interest Expense | — | ILA1.71 Million | — | ILA27.00K | ILA25.00K |
| Income Before Tax | ILA35.40 Million | ILA-9.71 Million | ILA-9.78 Million | ILA-33.64 Million | ILA-34.20 Million |
| Income Tax Expense | ILA54.00K | ILA4.52 Million | ILA8.97 Million | ILA58.00K | ILA-1.33 Million |
| Net Income | ILA35.34 Million | ILA-14.23 Million | ILA-18.75 Million | ILA-33.69 Million | ILA-34.20 Million |
Compugen Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Compugen's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | ILA156.87 Million | ILA115.00 Million | ILA121.33 Million | ILA94.18 Million | ILA132.16 Million |
| Total Current Assets | ILA148.02 Million | ILA106.00 Million | ILA114.58 Million | ILA86.12 Million | ILA123.22 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | ILA55.04 Million | ILA85.03 Million | ILA36.80 Million | ILA72.29 Million | ILA109.25 Million |
| Net Receivables | ILA294.00K | ILA269.00K | ILA61.32 Million | ILA317.00K | ILA188.00K |
| Inventory | — | — | — | ILA-2.46 Million | ILA-5.99 Million |
| Property, Plant & Equipment | — | — | — | ILA3.36 Million | ILA3.90 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | ILA54.14 Million | ILA60.08 Million | ILA55.77 Million | ILA16.50 Million | ILA25.47 Million |
| Total Current Liabilities | ILA22.57 Million | ILA20.16 Million | ILA26.27 Million | ILA11.92 Million | ILA17.10 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | ILA-87.64 Million | ILA-15.32 Million | ILA-12.54 Million | ILA-9.13 Million | ILA-5.05 Million |
| Total Stockholder Equity | ILA102.73 Million | ILA54.91 Million | ILA65.56 Million | ILA77.68 Million | ILA106.69 Million |
| Retained Earnings | ILA-453.41 Million | ILA-488.76 Million | ILA-474.53 Million | ILA-455.77 Million | ILA-422.08 Million |
Compugen Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Compugen generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | ILA31.63 Million | ILA49.60 Million | ILA-35.89 Million | ILA-34.11 Million | ILA-22.75 Million |
| Capital Expenditures | ILA306.00K | ILA118.00K | ILA172.00K | ILA487.00K | ILA292.00K |
| Free Cash Flow | ILA31.33 Million | ILA49.49 Million | ILA-36.06 Million | ILA-34.99 Million | ILA-23.04 Million |
| Investing Cash Flow | ILA29.99 Million | ILA-46.25 Million | ILA35.51 Million | ILA37.06 Million | ILA6.62 Million |
| Financing Cash Flow | ILA10.60 Million | ILA554.00K | ILA3.08 Million | ILA353.00K | ILA16.84 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | ILA1.88 Million | ILA3.02 Million | ILA3.55 Million | ILA4.33 Million | ILA4.28 Million |
| Depreciation | ILA475.00K | ILA486.00K | ILA476.00K | ILA482.00K | ILA461.00K |
| Change in Cash | ILA69.75 Million | ILA3.97 Million | ILA2.83 Million | ILA2.91 Million | ILA704.00K |
Compugen Earnings History — EPS Actual vs. Analyst Estimates
Track Compugen's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Nov 09, 2026 | — | -0.08 | — |
| Aug 03, 2026 | — | -0.08 | — |
| May 18, 2026 | — | — | — |
| Mar 03, 2026 | — | 0.14 | — |
| Nov 10, 2025 | — | -0.09 | — |
| Aug 05, 2025 | — | -0.08 | — |
| May 19, 2025 | -0.08 | -0.05 | -60.00% |
| Mar 04, 2025 | -0.07 | 0.07 | -200.00% |